Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc.
Your view on INBS
Overview
What the company does, where it operates, and who runs it.
About Intelligent Bio Solutions Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Harry Simeonidis
- Headquarters
- 142 West 57th Street, New York City, NY, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Harry Simeonidis
- Headquarters
- 142 West 57th Street, New York City, NY, US
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva.
The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Intelligent Bio Solutions Inc., and the rating behind it. INBS last traded at $2.13; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Intelligent Bio Solutions Inc.. Starting points for Intelligent Bio Solutions Inc.: EPS -$4.28, beta 4.25 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Intelligent Bio Solutions Inc.. Intelligent Bio Solutions Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Intelligent Bio Solutions Inc.. Trailing twelve-month EPS for Intelligent Bio Solutions Inc. stands at -$4.28. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Intelligent Bio Solutions Inc.. Intelligent Bio Solutions Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Intelligent Bio Solutions Inc. valued side by side against its closest peers. Intelligent Bio Solutions Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Intelligent Bio Solutions Inc., and how their positions are changing. At a $1.4M market value, institutional positions materially move Intelligent Bio Solutions Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Intelligent Bio Solutions Inc. executives and directors. Shares of Intelligent Bio Solutions Inc. have traded between $0.67 and $2.75 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Intelligent Bio Solutions Inc.. Intelligent Bio Solutions Inc. is a $1.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Intelligent Bio Solutions Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Intelligent Bio Solutions Inc.. Coverage tracks Intelligent Bio Solutions Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.